课题基金 / 基金详情

A 'Mitochondria-nucleus-ribosome' Signaling Axis Controls Lifespan in Mit Mutants

A 'Mitochondria-nucleus-ribosome' Signaling Axis Controls Lifespan in Mit Mutants
“线粒体-核-核糖体”信号轴控制线粒体突变体的寿命
批准号:
8840870
负责人:
SHANE L. REA
金额:
$17.89万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2017-04-30

项目摘要

项目成果

SHANE L. REA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of this study is to improve the health and well-being of older Americans. Our immediate goal is to examine how disruption of mitochondrial function is linked with the aging process. In recent years, it has become clear that defects in the electron transport chain of mitochondria, the key site of energy production in cells are linked with many age-related diseases - including heart disease, Type II diabetes, Parkinson Disease, Alzheimer's dementia, and cancer. 15% of the US population suffers from these chronic degenerative disorders. While it cannot yet be said that mitochondria cause these problems, it is clear that changes in mitochondria are involved, because their function is measurably altered. Perhaps most surprising has been the discovery of a number of mutants, across several species including mice, flies, nematodes and yeast, that paradoxically respond to mitochondrial electron transport chain dysfunction with increases in their lifespan. Investigation of this intriguing family of mutants is shedding new light on mitochondria and their role in aging. In this study, we will examine aging in the Caenorhabditis elegans Mit mutants, which are all long-lived and contain defective mitochondrial electron transport chain activity. We have uncovered evidence for a novel, three component signaling cascade in these mutants that links disruption of mitochondrial ETC activity with nuclear checkpoint signaling, blockade of cytoplasmic ribosomal translation, and lifespan control. This is a completely unexpected finding because these processes span three distinct cellular compartments. Our current study will define the cause and effects of this novel signaling cascade. We hypothesize that disruption of nucleotide synthesis in Mit mutants underlies activation of their nuclear checkpoint response. We have identified three checkpoint proteins that are activated in these animals, and now our preliminary data points toward a direct ribosomal target that potentially acts as a key longevity control point by regulating trafficking of nuclear-encoded proteins to the mitochondria. Our specific objectives will be determined if the biosynthesis of ribonucleotides is altered in Mit mutants. We will also determine if there is nuclear transcriptional stalling in these animals. Finally we will test whether our identified ribosomal target does indeed differentially act to control translation of nuclear-encoded mitochondrial ETC transcripts following checkpoint activation. We will address these questions through the use of powerful biochemical and genetic tools. We will use LC-MS/MS to quantify changes in nucleotide pools, quantitative PCR to determine if transcriptional stalling is occurring, and a combination of transgenic reporters, polysomal profiling and RNA Seq to determine if nuclear-encoded mitochondrial proteins are differentially prevented from being translated in Mit mutants.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbabio.2015.05.021
发表时间: 2015-11
期刊: Biochimica et biophysica acta
影响因子: --
作者: []
通讯作者:
Maintaining Mitochondrial Health into Old Age
  • 批准号:
    9762772
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2017
  • 负责人:
    SHANE L. REA
  • 依托单位:
Maintaining Mitochondrial Health into Old Age
  • 批准号:
    10341083
  • 项目类别:
  • 资助金额:
    $37.58万
  • 财政年份:
    2017
  • 负责人:
    SHANE L. REA
  • 依托单位:
A 'Mitochondria-nucleus-ribosome' Signaling Axis Controls Lifespan in Mit Mutants
Alternate Modes of Energy Production and clk-1 Life Extension
  • 批准号:
    7243998
  • 项目类别:
  • 资助金额:
    $6.84万
  • 财政年份:
    2006
  • 负责人:
    SHANE L. REA
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: